[HTML][HTML] Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective

RWH Hui, LY Mak, TT Cheung, VHF Lee… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic
hepatitis B is the most common HCC etiology in our region. With the high case load …

Salvage external beam radiotherapy after incomplete transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis and systematic review

DS Yang, S Park, CH Rim, WS Yoon, IS Shin, HA Lee - Medicina, 2021 - mdpi.com
Background and objective: Although transarterial chemoembolization (TACE) has been the
commonest local modality for hepatocellular carcinoma (HCC), incomplete repsonse occurs …

Association of multi-phasic MR-based radiomic and dosimetric features with treatment response in unresectable hepatocellular carcinoma patients following novel …

LM Ho, SK Lam, J Zhang, CL Chiang, ACY Chan, J Cai - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the most prevalent and
devastating malignancies worldwide. An ongoing phase-II clinical trial assesses the efficacy …

Planning benchmark study for stereotactic body radiation therapy of liver metastases: results of the DEGRO/DGMP working group on stereotactic radiation therapy and …

C Moustakis, O Blanck, M ka heng Chan… - International Journal of …, 2022 - Elsevier
Purpose Our purpose was to investigate whether liver stereotactic body radiation therapy
treatment planning can be harmonized across different treatment planning systems, delivery …

Clinical relevance of reductive hepatectomy for Barcelona clinic liver cancer stages B and C advanced hepatocellular carcinoma: a single-center experience of 102 …

S Komatsu, M Kido, M Tanaka, K Kuramitsu… - World Journal of …, 2019 - Springer
Background This study aimed to evaluate the clinical relevance of hepatectomy for
Barcelona Clinic Liver Cancer (BCLC) stages B and C advanced hepatocellular carcinoma …

Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma

D Hong, Y Zhou, X Wan, H Su, H Shao - Bmc Cancer, 2021 - Springer
Background There is currently no widely-accepted consensus for the management of
hepatocellular carcinoma with portal vein tumor thrombus. We evaluate the safety and …

Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting

G Sabine, C Heinz, B Claus, F Walter… - Strahlentherapie …, 2020 - search.proquest.com
Methods We retrospectively analyzed 36 patients (45 lesions) treated between 2011 and
2017. Twenty-seven had previous treatments. Current treatment consisted of SBRT alone …

Stereotactic body radiation therapy with or without transarterial chemoembolization versus transarterial chemoembolization alone in early-stage hepatocellular …

MP Dumago, RAF Agas, CJE Jainar, ET Yap… - Journal of …, 2023 - Springer
Purpose This study aims to review the current evidence on the utility of stereotactic body
radiation therapy (SBRT), with or without transarterial chemoembolization (TACE), for early …

Efficacy and prognostic factors of trans-arterial chemoembolization combined with stereotactic body radiation therapy for BCLC stage B hepatocellular carcinoma

C Jiang, S Jing, H Zhou, A Li, X Qiu, X Zhu… - Frontiers in …, 2021 - frontiersin.org
Purpose This study aimed to evaluate the efficacy and safety of trans-arterial
chemoembolization (TACE) followed by stereotactic body radiation therapy (SBRT) in …

Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy: A retrospective study

AA Mohamed, ML Berres, P Bruners, SA Lang… - Strahlentherapie und …, 2024 - Springer
Purpose Hepatocellular carcinoma (HCC) poses a unique challenge due to its predilection
for developing on compromised livers, often limiting surgical options. Stereotactic body …